menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Fresenius Launches Otulfi (Ustekinumab-aauz) in U.S.

    BUSINESSWIRE

    Blue Shield of California Slashes Cost of World`s Best-selling Drug

    PR NEWSWIRE

    Fresenius Kabi And AABB Announce 19th Annual Blood Collectors Week Sept 1-7

    BUSINESSWIRE

    Fresenius Kabi Expands Women`s Health Portfolio With Generic Option

    BUSINESSWIRE

    Fresenius Kabi Wins Premier Inc.`s 2024 Trailblazer Award

    BUSINESSWIRE

    Arunesh Verma Joins Fresenius Kabi USA as President

    BUSINESSWIRE

    Fresenius Launches Subcutaneous Tyenne In US Market

    BUSINESSWIRE

    MAbxience Names New Chief Executive Officer

    CONTRACT PHARMA

    Fresenius Momentum In (Bio)Pharma, Launches Tyenne® Biosimilar

    BUSINESSWIRE

    Kabi’s Manufacturing Site in Norway taken over by Prange and Adragos

    PRESS RELEASE

    Fresenius Kabi Further Expands Oncology Portfolio

    BUSINESSWIRE

    Healthcare group Fresenius tops Q4 operating profit forecast

    REUTERS

    Fresenius Launches Posaconazole Injection for Treatment of Fungal Infections

    BUSINESSWIRE

    Fresenius Kabi and Mayo Clinic Enter into Agreement for Ivenix® Infusion System

    BUSINESSWIRE

    Prange And Adragos Acquire Fresenius Kabi`s Norway Manufacturing Site

    PRESS RELEASE

    Fresenius Kabi`s Biologic Idacio (adalimumab) Receives Approval in the U.S.

    FDA

    Fresenius Celebrates 25th Anniversary of National Blood Donation Hall of Fame

    BUSINESSWIRE

    Fresenius Kabi Introduces Smart Labels for Diprivan

    BUSINESSWIRE

    Fresenius Kabi Named 2023 Supplier Partner of the Year by Vizient

    BUSINESSWIRE

    Fresenius Kabi Selected for Year to Exhibit the Ivenix Infusion System

    BUSINESSWIRE

    FDA turns to Fresenius imports from EU to help with common cancer drug shortage

    ENDPTS

    Tyenne, Fresenius Kabi’s tocilizumab biosimilar, receives EC approval

    PRESS RELEASE

    Virginia Associates Chooses the Ivenix Infusion System from Fresenius Kabi

    BUSINESSWIRE

    Fresenius Kabi and AABB Announce Start of 18th Annual Blood Collectors Week

    BUSINESSWIRE

    Fresenius Kabi Launches Plerixafor Injection

    BUSINESSWIRE

    Fresenius Kabi Expands Radiology Portfolio with Launch of Gadobutrol Injection

    BUSINESSWIRE

    J&J`s Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal

    FIERCE PHARMA

    Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory

    REUTERS

    Fresenius` Generic Sodium Chloride Receives Approval in the U.S.

    FDA

    Fresenius Kabi Introduces New Presentation for Fentanyl Citrate Injection

    BUSINESSWIRE

    Expanding Access to Women’s Health Fresenius Kabi Launches Fertility Treatment

    BUSINESSWIRE

    Fresenius launches biosimilar version of AbbVie`s Humira at 5% discount

    REUTERS

    Fresenius Kabi Broadens Radiology Portfolio with its Market Authorized Generic

    BUSINESSWIRE

    Fresenius Kabi Launches Vasopressin Injection

    BUSINESSWIRE

    Fresenius Kabi Expands Ready-to-Administer Portfolio with Diazepam Injection

    BUSINESSWIRE

    Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection

    BUSINESSWIRE

    CMS grants Fresenius Kabi permanent, product-specific Q-Code for Stimufend®

    BUSINESSWIRE

    Stimufend® (pegfilgrastim-fpgk) Now Available in the United States

    BUSINESSWIRE

    Fresenius` Generic Ketamine Hydrochloride Receives Approval in the U.S.

    FDA

    Fresenius Kabi’s Ivenix Infusion System Goes Live at San Luis Valley Health

    BUSINESSWIRE

    Fresenius` Generic Zinc Sulfate Monohydrate Receives Approval in the U.S.

    FDA

    Fresenius Targets Treatment of Seizures with Generic Lacosamide Injection

    BUSINESSWIRE

    Fresenius nabs the latest Humira biosimilar approval

    ENDPTS

    Fresenius` Biologic Idacio ( Adalimumab) Receives Approval in the U.S.

    FDA

    Fresenius Kabi Introduces Pralatrexate Injection for the Treatment of Lymphoma

    BUSINESSWIRE

    Ferinject approved in China for the treatment of iron deficiency in patients

    PHARMTECH

    Ferinject approved in Chinafor the treatment of iron deficiency in patients

    BUSINESSWIRE

    Fresenius`s Generic Diazepam Receives Approval in the U.S.

    FDA

    Fresenius` new CEO signals `reset` as activist investor circles

    FIERCEPHARMA

    Fort Goes Live with Smart Pump Interoperability with Ivenix Infusion System

    BUSINESSWIRE

    Fresenius Kabi Named 2022 Pharmaceutical Supplier Partner of the Year by Vizient

    BUSINESSWIRE

    Fresenius Kabi Launches Gadoterate Meglumine Injection, USP

    BUSINESSWIRE

    ScaleReady Introduces the Cue® Cell Processing System From Fresenius Kabi

    BUSINESSWIRE

    Fresenius Kabi receives U.S. FDA approval for biosimilar Stimufend

    PRESS RELEASE

    Fresenius`s Biologic Stimufend (Pegfilgramstim) Receives Approval in the U.S.

    FDA

    Fresenius Kabi, Introduces Data Matrix Barcodes on all Drugs

    BUSINESS WIRE

    Fresenius Kabi`s Sugammadex Receives Approval in the EMA

    EMA

    Romidepsin for Injection Available from Fresenius Kabi

    BUSINESSWIRE

    Fagron expands its US sterile compounding footprint with East coast acquisition

    GLOBENEWSWIRE

    Fresenius Kabi Expands RFID Compatibility for Hospital Inventory Management

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.